Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Scientific Reports
|
October 21, 2025
PARP inhibitor and PRMT5 inhibitor synergy is independent of BRCA1/2 and MTAP status in breast cancer cells
Samyuktha Suresh, Lisa McPherson, James M Ford
Molecular and Cellular Biology
|
November 1, 2006
Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes
Yong-Tae Ahn, Boli Huang, Lisa McPherson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2007
Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription
Boli Huang, Yong-Tae Ahn, Lisa McPherson, et al.
BMC Pharmacology
|
July 21, 2011
Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells
Elizabeth Alli, Vandana B Sharma, Anne-Renee Hartman, et al.
ACS Medicinal Chemistry Letters
|
June 17, 2026
A SMUG1 Inhibitor Modulates the Excision of Pyrimidine DNA Damage
Pavitra S Thacker, Yixuan Gao, Lisa McPherson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 20, 2007
Kruppel-like transcription factor 13 regulates T lymphocyte survival in vivo
Meixia Zhou, Lisa McPherson, Dongdong Feng, et al.
DNA Repair
|
January 29, 2025
Small-molecule activator of SMUG1 enhances repair of pyrimidine lesions in DNA
Yixuan Gao, Lisa McPherson, Shanthi Adimoolam, et al.
ACS Chemical Biology
|
July 13, 2022
Enhancing Repair of Oxidative DNA Damage with Small-Molecule Activators of MTH1
Yujeong Lee, Yoshiyuki Onishi, Lisa McPherson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2014
Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment
Allison W Kurian, Emily E Hare, Meredith A Mills, et al.
Molecular Cancer Therapeutics
|
November 21, 2019
The Existence of MTH1-independent 8-oxodGTPase Activity in Cancer Cells as a Compensatory Mechanism against On-target Effects of MTH1 Inhibitors
Govindi J Samaranayake, Clara I Troccoli, Ling Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Scientific Reports
|
October 21, 2025
PARP inhibitor and PRMT5 inhibitor synergy is independent of BRCA1/2 and MTAP status in breast cancer cells
Samyuktha Suresh, Lisa McPherson, James M Ford
Molecular and Cellular Biology
|
November 1, 2006
Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes
Yong-Tae Ahn, Boli Huang, Lisa McPherson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2007
Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription
Boli Huang, Yong-Tae Ahn, Lisa McPherson, et al.
BMC Pharmacology
|
July 21, 2011
Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells
Elizabeth Alli, Vandana B Sharma, Anne-Renee Hartman, et al.
ACS Medicinal Chemistry Letters
|
June 17, 2026
A SMUG1 Inhibitor Modulates the Excision of Pyrimidine DNA Damage
Pavitra S Thacker, Yixuan Gao, Lisa McPherson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 20, 2007
Kruppel-like transcription factor 13 regulates T lymphocyte survival in vivo
Meixia Zhou, Lisa McPherson, Dongdong Feng, et al.
DNA Repair
|
January 29, 2025
Small-molecule activator of SMUG1 enhances repair of pyrimidine lesions in DNA
Yixuan Gao, Lisa McPherson, Shanthi Adimoolam, et al.
ACS Chemical Biology
|
July 13, 2022
Enhancing Repair of Oxidative DNA Damage with Small-Molecule Activators of MTH1
Yujeong Lee, Yoshiyuki Onishi, Lisa McPherson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2014
Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment
Allison W Kurian, Emily E Hare, Meredith A Mills, et al.
Molecular Cancer Therapeutics
|
November 21, 2019
The Existence of MTH1-independent 8-oxodGTPase Activity in Cancer Cells as a Compensatory Mechanism against On-target Effects of MTH1 Inhibitors
Govindi J Samaranayake, Clara I Troccoli, Ling Zhang, et al.
Page
of 2